Look At Analyst Expectations For A Better Read On Keurig Dr Pepper Inc (NASDAQ: KDP)

Currently, there are 1.36B common shares owned by the public and among those 1.13B shares have been available to trade.

The company’s stock has a 5-day price change of -2.41% and -15.69% over the past three months. KDP shares are trading -4.17% year to date (YTD), with the 12-month market performance down to -3.12% lower. It has a 12-month low price of $28.61 and touched a high of $38.28 over the same period. KDP has an average intraday trading volume of 11.07 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.04%, -5.21%, and -9.26% respectively.

Institutional ownership of Keurig Dr Pepper Inc (NASDAQ: KDP) shares accounts for 72.68% of the company’s 1.36B shares outstanding.

It has a market capitalization of $41.75B and a beta (3y monthly) value of 0.62. The stock’s trailing 12-month PE ratio is 18.63, while the earnings-per-share (ttm) stands at $1.65. The company has a PEG of 2.63 and a Quick Ratio of 0.34 with the debt-to-equity ratio at 0.66. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.46% over the week and 1.86% over the month.

Earnings per share for the fiscal year are expected to increase by 7.05%, and 6.50% over the next financial year. EPS should shrink at an annualized rate of 7.09% over the next five years, compared to 23.74% over the past 5-year period.

Looking at the support for the KDP, a number of firms have released research notes about the stock. Piper Sandler stated their Neutral rating for the stock in a research note on January 07, 2025, with the firm’s price target at $35. Deutsche Bank coverage for the Keurig Dr Pepper Inc (KDP) stock in a research note released on December 12, 2024 offered a Buy rating with a price target of $39. Citigroup was of a view on September 23, 2024 that the stock is Buy, while Exane BNP Paribas gave the stock Neutral rating on June 24, 2024, issuing a price target of $36. Truist on their part issued Hold rating on June 17, 2024.

Most Popular

Related Posts